Navigation Links
Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful
Date:12/1/2008

INDIANAPOLIS, Dec. 1 /PRNewswire/ -- Roche announced today that a comparative study conducted to evaluate differences in perceived pain and discomfort associated with blood glucose testing showed ACCU-CHEK blood glucose monitoring systems and lancing devices were deemed least painful.

Results indicated that, overall, the ACCU-CHEK Aviva and ACCU-CHEK Compact Plus blood glucose monitoring systems and the ACCU-CHEK Multiclix, ACCU-CHEK Softclix and ACCU-CHEK Softclix Plus lancing devices were least painful when compared to competitors. Those competitors were:

    System                   Lancing Device
    Ascensia(R) Contour(R)   Microlet(R)/Vaculance(R)
    Freestyle Freedom(R)     TheraSense(R) Freestyle(R)
    OneTouch(R) Ultra(R)2    LifeScan UltraSoft(R)

"We are pleased a recent study confirms that our products are perceived as least painful for all three testing sites included in the study-finger, palm and forearm," said Roche Director of Product Marketing Jennifer Aspy. "Our patented, precision-guided technology is what makes the difference because there is no vibration when the lancet enters or exits the skin."

Aspy added that this vibration, which occurs with conventional technology, causes side-to-side motion. This motion coupled with the lancet stopping abruptly and then bouncing back result in painful tissue damage. The technology used in the ACCU-CHEK products works in an entirely different way to greatly reduce this painful damage. ACCU-CHEK lancing devices also offer 11 depth settings, so patients can find a lancing depth to match their skin type. This customized depth penetration avoids painful nerve endings. And high-quality ACCU-CHEK lancets use comfortable, thin 28- and 30-gauge lancets with beveled tips. Lower-quality lancets use larger needles, and many lack the beveled tips, causing skin trauma.

The study consisted of 165 subjects who tested at hom
'/>"/>

SOURCE Roche Diabetes Care
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S.
2. Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention
3. PreMD Inc. Enters Clinical Study with Cosmetics Conglomerate
4. Third Pivotal Phase 3 Study for NicOx Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results
5. Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia
6. Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351
7. Seniors Can Be Heartened by New Study on Statins
8. Soft Contact Lenses Do Not Lead to Myopic Creep in Children, Study Shows
9. Miami Jewish Home and Hospital, Berma Research Group and Segal Institute for Clinical Research Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimers Disease
10. Alba Therapeutics Announces Enrollment of Its First European Patient in Global Phase IIb Study of Larazotide Acetate for Treatment of Active Celiac Disease
11. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...s treated at the initial dose in an ongoing Phase ...d decline after three days , , Conference Call ...ewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc....e first cohort of an ongoing Phase Ib clinical tri...cleoside polymerase inhibitor. ANA598 was very we...
(Date:1/7/2009)..., Tenn., Jan. 7 Scienti...ct a high likelihood of relapse in children with a...searchers caution that further research is needed ...1 or IKAROS, lead to leukemia relapse, the find...agnostic tests to assess the risk of treatment fai...
(Date:1/7/2009)...CK, Md., Jan. 7 ImQuest Life Scien...n IND application to the Food and Drug Administrat...ad pyrimidinedione HIV inhibitor IQP-0410. ImQuest...he first quarter of 2009. IQP-0410 is a novel smal...s a nonnucleoside reverse transcriptase inhibitor ...
(Date:1/7/2009)..., Jan. 7 Tiantan Puhua Hospital St... the worldwide leader in using stem cells to effec...ay six new globally experienced additions to its m...d the hospital,s treatment capabilities for growin...six senior doctors include the distinguished Dr. J...
Breaking Medicine Technology:ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 3ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 4ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 6Gene Abnormality Found to Predict Childhood Leukemia Relapse 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 4Gene Abnormality Found to Predict Childhood Leukemia Relapse 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 6ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 3Pivotal Data Showed SYMBICORT 28R 29 Improved Lung Function in Adults with COPD 3367 1Pivotal Data Showed SYMBICORT 28R 29 Improved Lung Function in Adults with COPD 3367 2Pivotal Data Showed SYMBICORT 28R 29 Improved Lung Function in Adults with COPD 3367 3Pivotal Data Showed SYMBICORT 28R 29 Improved Lung Function in Adults with COPD 3367 4Pivotal Data Showed SYMBICORT 28R 29 Improved Lung Function in Adults with COPD 3367 5Pivotal Data Showed SYMBICORT 28R 29 Improved Lung Function in Adults with COPD 3367 6Pivotal Data Showed SYMBICORT 28R 29 Improved Lung Function in Adults with COPD 3367 7Pivotal Data Showed SYMBICORT 28R 29 Improved Lung Function in Adults with COPD 3367 8The American Journal of Nursing honors Jean and Ric Edelman 28137 1The American Journal of Nursing honors Jean and Ric Edelman 28137 2The American Journal of Nursing honors Jean and Ric Edelman 28137 3Hagens Berman Sobol Shapiro 3A Class Action Filed Against Spectranetics 28134 1Hagens Berman Sobol Shapiro 3A Class Action Filed Against Spectranetics 28134 2Hagens Berman Sobol Shapiro 3A Class Action Filed Against Spectranetics 28134 3Hagens Berman Sobol Shapiro 3A Class Action Filed Against Spectranetics 28134 4mtvU and The Jed Foundation Ask Students How Are You A Friend 3F 28131 1mtvU and The Jed Foundation Ask Students How Are You A Friend 3F 28131 2mtvU and The Jed Foundation Ask Students How Are You A Friend 3F 28131 3mtvU and The Jed Foundation Ask Students How Are You A Friend 3F 28131 4mtvU and The Jed Foundation Ask Students How Are You A Friend 3F 28131 5mtvU and The Jed Foundation Ask Students How Are You A Friend 3F 28131 6
... protein,protects human pancreatic cancer cells fr... of the body,s natural defenses against,out-of-con... Texas,M. D. Anderson Cancer Center report in the ...otein tissue transglutaminase, known by the abbrev...rs at M. D. Anderson and,elsewhere to be overexpre...
...cal studies have,shown (1) similar rates of neurol... patients being treated with Tamiflu compared to,t...urthermore,recent data derived from US health ins...00 influenza patients treated with Tamiflu,and ove...ve shown,that the Tamiflu treated patients showed ...
Other Medicine Technology:Protein Found to Shield Pancreatic Cancer Cells from,Self-Destruction 2Protein Found to Shield Pancreatic Cancer Cells from,Self-Destruction 3New Data from the US and Japan Support: No Established Causal Link,Between Neuropsychiatric Symptoms and Treatment with Tamiflu US,Databases Indicate Psychiatric Symptoms Lower in Influenza Patients,Taking Tamiflu Versus Those Not Taking Tamiflu 2New Data from the US and Japan Support: No Established Causal Link,Between Neuropsychiatric Symptoms and Treatment with Tamiflu US,Databases Indicate Psychiatric Symptoms Lower in Influenza Patients,Taking Tamiflu Versus Those Not Taking Tamiflu 3New Data from the US and Japan Support: No Established Causal Link,Between Neuropsychiatric Symptoms and Treatment with Tamiflu US,Databases Indicate Psychiatric Symptoms Lower in Influenza Patients,Taking Tamiflu Versus Those Not Taking Tamiflu 4
(Date:1/8/2009)...RNewswire-FirstCall/ - Med-Emerg International Inc...ng providers of health services, is pleased to ann...f the previously announced plan of arrangement (th...) at a special meeting of MedEmerg,s shareholders ...es cast at the meeting were in favour of the Arran...
(Date:1/8/2009)...PRNewswire/ -- New York City Mayor Michael R. Bloo...ion Day" and presented a proclamation to Ilchi Lee...n Association) and developer of Brain Education, a...ance health, well-being, and mental ability for al...r regarding the power of individuals to change the...
(Date:1/8/2009)...Newswire-USNewswire/ -- The Alliance for the Prude...new marketing campaigns by Wal-Mart, Stop and Shop...prescribed antibiotics to customers. These offers ...y lead to increased costs in the form of treatment... the public,s need for affordable healthcare is in...
(Date:1/8/2009)...ssment for heart risk may not be accurate in some ...ws) -- Two studies, from the United States and the...he long-established Framingham Risk Score in predi... The Framingham score, based on findings of a deca...lows doctors to assess risk on the basis of seven ...
Breaking Medicine News(10 mins):Health News:Shareholders of Med-Emerg International Inc. approve plan of arrangement with AIM Health Group Inc. 2Health News:NYC Mayor Michael R. Bloomberg Declares January 8th 'IBREA Brain Education Day' 2Health News:Antibiotics as Loss Leaders? 2Health News:Studies Challenge Framingham Risk Score 2Health News:Studies Challenge Framingham Risk Score 3
...be treated by using state-of-the-art gene therapy ...field have developed a way of blasting DNA into ce...in caused when the heart is starved of blood due t...t may precede a heart attack. In many cases this i...
...f inheritable genes to enable people to produce mo...ttitudes to family relationships and on being huma...spiring parents with inheritable diseases hold out...offers them the possibility of avoiding passing di...
...p forward in dissecting the pathways and mechanism...hers of Yale University have seen a break through ...e adult onset Type II Diabetes mellitus. The...g a gene that produces the enzyme called Akt2 or /...
...rchers, patients suffering from Angina may have so...rapy or doses of antibiotics. Angina, a common car...all over the world, is severe chest pain caused by...od to the heart during// physical activity. Curren...
Other Medicine News:Health News:Perfect babies boon or a bane? 2Health News:Breakthrough in Type II Diabetes 2Health News:Antibiotic, Gene Therapy Help Treat Angina 2Health News:Antibiotic, Gene Therapy Help Treat Angina 3
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
Medicine Products: